Subgroup analyses were performed to further explore the associations between the AIP and clinical outcomes, adjusting for confounders such as age, sex, CVD history, diabetes history, BMI, ALB, UA, calcium, LDL-C, BUN, iPTH, glucose, Hb, and lipid-lowering medication use (Figure 3). This evidence concerns the gene GSTM1 and diabetes mellitus.